• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Jumps 200 Points; US Weekly Jobless Claims Fall

    3/21/24 9:47:49 AM ET
    $ASST
    $KAVL
    $MVLA
    $TRML
    Computer Software: Prepackaged Software
    Technology
    Other Consumer Services
    Consumer Discretionary
    Get the next $ASST alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Thursday.

    Following the market opening Thursday, the Dow traded up 0.52% to 39,718.37 while the NASDAQ rose 0.84% to 16,506.28. The S&P 500 also rose, gaining, 0.53% to 5,252.23.

    Check This Out: Micron, Accenture And 3 Stocks To Watch Heading Into Thursday

     

    Leading and Lagging Sectors

     

    Information technology shares rose by 0.9% on Thursday.

    In trading on Thursday, consumer staples shares fell by 0.1%.

     

    Top Headline

     

    U.S. initial jobless claims declined by 2,000 to 210,000 on the week ending March 16, versus market estimates of 215,000.

     

    Equities Trading UP

     

    Yield10 Bioscience, Inc. (NASDAQ:YTEN) shares shot up 171% to $0.6590 after the company announced that the USDA-APHIS Biotechnology Regulatory Services determined that the Camelina sativa varieties may be planted and bred in the United States.

    Shares of Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) got a boost, surging 104% to $2.71 after falling 11% on Wednesday.

    Asset Entities Inc. (NASDAQ:ASST) shares were also up, gaining 36% to $0.7128 after the company announced that it entered into an agreement with Zendrop.

     

    Equities Trading DOWN

     

    Movella Holdings Inc. (NASDAQ:MVLA) shares dropped 61% to $0.1110 after the company announced that it will voluntarily delist from the Nasdaq.

    Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) were down 38% to $27.78. Tourmaline Bio recently posted a fourth-quarter loss of 81 cents per share.

    Intelligent Group Limited (NASDAQ:INTJ) was down, falling 28% to $2.38. Intelligent Group priced initial public offering of 1,875,000 ordinary shares at $4 per share.

    Also Check This Out: Alphabet, Jabil And 2 Other Stocks Insiders Are Selling

     

    Commodities

     

    In commodity news, oil traded down 0.5% to $80.85 while gold traded up 2.2% at $2,208.90.

    Silver traded up 2.2% to $25.65 on Thursday, while copper rose 0.7% to $4.0785.

     

    Euro zone

     

    European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.5%, London’s FTSE 100 jumped 1.1% while Spain’s IBEX 35 Index rose 0.9% The German DAX rose 0.4% French CAC 40 fell 0.2% while Italy’s FTSE MIB Index gained 0.1%.

    The HCOB Eurozone manufacturing PMI declined to a three-month low level of 45.7 in March, while services PMI increased to 51.1 from 50.2. The Eurozone posted a current account surplus of €24.87 billion in January versus a year-ago deficit of €11.9 billion. Passenger car registrations in the European Union surged 10.1% year-over-year to 883.6 thousand units for February.

    The HCOB Germany composite PMI climbed to 47.4 in March from 46.3 a month ago, while French composite PMI declined to 47.7 in March from 48.1 in February. The S&P Global UK services PMI fell to 53.4 in March from 53.8 in the previous month, while manufacturing PMI climbed to 49.9 in March from 47.5.

     

    Asia Pacific Markets

     

    Asian markets closed mostly higher on Thursday, with Japan’s Nikkei 225 surging 2.03%, Hong Kong’s Hang Seng Index rising 1.93%, China’s Shanghai Composite Index falling 0.08% and India’s S&P BSE Sensex gaining 0.75%.

    The annual inflation rate in Hong Kong accelerated to 2.1% in February from January’s reading of 1.7%. Hong Kong's current account surplus increased to HKD 71.2 billion in the fourth quarter from HKD 55.9 billion in the year-ago period. The Hong Kong Monetary Authority kept its base rate unchanged at 5.75%.

    The HSBC Flash India composite PMI increased to 61.4 in March versus a final reading of 60.6. The au Jibun Bank Japan composite PMI surged to 52.3 in March versus a final reading of 50.6 in February. Japan's trade deficit narrowed to JPY 379,358 billion in February from JPY 928.908 billion in the year-ago period.

     

    Economics

     

    The Philadelphia Fed Manufacturing Index in fell to 3.2 in March from 5.2 in the previous month.

    U.S. initial jobless claims declined by 2,000 to 210,000 on the week ending March 16, versus market estimates of 215,000.

    The U.S. current account deficit shrank by $1.6 billion to $194.8 billion during the fourth quarter, compared to market estimates for a $209 billion gap.

    Now Read This: Top 3 Tech Stocks That Could Lead To Your Biggest Gains In March

    Get the next $ASST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASST
    $KAVL
    $MVLA
    $TRML

    CompanyDatePrice TargetRatingAnalyst
    Tourmaline Bio Inc.
    $TRML
    4/23/2025$70.00Buy
    Chardan Capital Markets
    Tourmaline Bio Inc.
    $TRML
    3/6/2025$42.00Outperform
    Wedbush
    Tourmaline Bio Inc.
    $TRML
    12/6/2024$50.00Outperform
    BMO Capital Markets
    Tourmaline Bio Inc.
    $TRML
    11/11/2024$48.00 → $49.00Buy
    H.C. Wainwright
    Yield10 Bioscience Inc.
    $YTEN
    2/8/2024Buy → Hold
    Lake Street
    Tourmaline Bio Inc.
    $TRML
    12/15/2023$41.00Buy
    Jefferies
    Tourmaline Bio Inc.
    $TRML
    12/4/2023$48.00Buy
    H.C. Wainwright
    Tourmaline Bio Inc.
    $TRML
    11/17/2023$43.00Buy
    Truist
    More analyst ratings

    $ASST
    $KAVL
    $MVLA
    $TRML
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Pham Benjamin

    4 - Strive, Inc. (0001920406) (Issuer)

    1/16/26 6:06:16 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Chief Legal Officer Beirne Brian Logan

    4 - Strive, Inc. (0001920406) (Issuer)

    1/16/26 6:03:11 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Director Semler Eric was granted 15,032,162 shares (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    1/16/26 6:00:59 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ASST
    $KAVL
    $MVLA
    $TRML
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chardan Capital Markets initiated coverage on Tourmaline with a new price target

    Chardan Capital Markets initiated coverage of Tourmaline with a rating of Buy and set a new price target of $70.00

    4/23/25 8:18:16 AM ET
    $TRML
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Wedbush initiated coverage on Tourmaline with a new price target

    Wedbush initiated coverage of Tourmaline with a rating of Outperform and set a new price target of $42.00

    3/6/25 7:32:45 AM ET
    $TRML
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BMO Capital Markets initiated coverage on Tourmaline with a new price target

    BMO Capital Markets initiated coverage of Tourmaline with a rating of Outperform and set a new price target of $50.00

    12/6/24 8:19:37 AM ET
    $TRML
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ASST
    $KAVL
    $MVLA
    $TRML
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Cole Matthew Ryan bought $459,350 worth of shares (500,000 units at $0.92), increasing direct ownership by 190% to 763,012 units (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    1/14/26 8:45:26 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Cole Matthew Ryan bought $415,999 worth of shares (515,195 units at $0.81), increasing direct ownership by 373% to 263,012 units (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    12/16/25 9:04:18 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Large owner Ramaswamy Vivek bought $1,250,000 worth of Variable Rate Series A Perpetual Preferred Stock (15,625 units at $80.00) (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    11/7/25 6:50:59 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ASST
    $KAVL
    $MVLA
    $TRML
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Strive Announces Closing of Upsized & Oversubscribed Follow-On Offering of SATA Stock and Concurrent Exchange of Semler Notes

    DALLAS, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced the closing of its follow-on offering (the "offering") of 1,320,000 shares of Strive's Variable Rate Series A Perpetual Preferred Stock (the "SATA Stock"), at a public offering price of $90 per share. The Company announced over $600 million in demand for the SATA Stock from the follow-on offering and upsized the initial $150 million target raise to $225 million, when taken together with the concurrent privately negotiated notes exchanges described below. As described below, the Company has now retired $110 million of the $120 million aggregate principal amount of debt th

    1/28/26 8:41:41 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Strive Announces Pricing of Upsized Follow-On Offering of SATA Stock and Concurrent Exchange of Semler Notes

    DALLAS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:SATA) ("Strive" or the "Company") today announced the pricing of its follow-on offering (the "offering") on January 22, 2026 of 1,320,000 shares of Strive's Variable Rate Series A Perpetual Preferred Stock (the "SATA Stock"), an upsize over the $150 million transaction size previously announced when taken together with the anticipated privately negotiated notes exchanges, at an offering price of $90 per share. Strive intends to use the net proceeds of this offering, together with cash on hand and potentially cash from terminating Strive's existing capped call transactions relating to the outstanding 4.25% Convertible Senior No

    1/22/26 9:51:31 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Strive Announces Proposed Follow-On Offering of SATA Stock

    DALLAS, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:SATA) ("Strive" or the "Company") today announced that, subject to market and other conditions, it intends to conduct a $150 million follow-on offering (the "offering") registered under the Securities Act of 1933, as amended (the "Securities Act"), of shares of Strive's Variable Rate Series A Perpetual Preferred Stock (the "SATA Stock"). Strive intends to use the net proceeds of this offering, together with cash on hand and potentially cash from terminating Strive's existing capped call transactions relating to the outstanding 4.25% Convertible Senior Notes due 2030 (the "Semler Convertible Notes") issued by Semler Scientific,

    1/21/26 4:15:00 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ASST
    $KAVL
    $MVLA
    $TRML
    SEC Filings

    View All

    SEC Form S-8 filed by Strive Inc.

    S-8 - Strive, Inc. (0001920406) (Filer)

    2/5/26 5:17:30 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Kaival Brands Innovations Group Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Kaival Brands Innovations Group, Inc. (0001762239) (Filer)

    2/5/26 5:16:35 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Strive Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Strive, Inc. (0001920406) (Filer)

    2/3/26 4:29:55 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ASST
    $KAVL
    $MVLA
    $TRML
    Financials

    Live finance-specific insights

    View All

    Strive Increases SATA Perpetual Preferred Stock Dividend to 12.25%

    DALLAS, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced an increase in the dividend rate on its Variable Rate Series A Perpetual Preferred Stock (the "SATA Stock"), raising the annual dividend rate to 12.25%, up from 12.00%. The increased dividend reflects Strive's continued commitment to enhancing shareholder value while maintaining disciplined management of its capital structure. The annual dividend rate is based on the $100 stated amount per share and is payable in monthly installments subject to declaration by Strive's board of directors. When declared, this corresponds to an annual dividend of approximately $12.25 per s

    12/15/25 8:30:00 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Strive Announces $500,000,000 SATA At-The-Market Program

    DALLAS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced that it has entered into a sales agreement pursuant to which Strive may issue and sell shares of its Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share (the "SATA Stock"), having an aggregate offering price of up to $500,000,000 (the "ATM Program"). Strive intends to use the net proceeds from the ATM Program for general corporate purposes, including, among other things, the acquisition of bitcoin and bitcoin-related products and for working capital, the purchase of income generating assets to grow the Company's business, other capital expenditur

    12/9/25 6:27:45 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights

    – Reported positive topline results from the ongoing Phase 2 TRANQUILITY trial of pacibekitug in May 2025, demonstrating rapid, deep, and durable reductions in high-sensitivity C-reactive protein with quarterly dosing – — Additional data from the ongoing Phase 2 TRANQUILITY trial to be presented at the European Society of Cardiology Congress in August 2025 – – On track to initiate Phase 2 proof-of-concept trial in abdominal aortic aneurysm in the second half of 2025 – – Planning underway for a Phase 3 cardiovascular outcomes trial in atherosclerotic cardiovascular disease – – Cash, cash equivalents, and investments of $256.4 million as of June 30, 2025, provide expected cash runw

    8/13/25 7:00:00 AM ET
    $TRML
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ASST
    $KAVL
    $MVLA
    $TRML
    Leadership Updates

    Live Leadership Updates

    View All

    Strive Announces the Completion of Semler Scientific Acquisition

    DALLAS, TX, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST) ("Strive") today announced the successful completion of the previously announced acquisition of Semler Scientific. Strive now holds approximately 12,797.9 bitcoin, becoming the #11 largest public corporate holder of bitcoin globally. Strive also announces the appointment of Avik Roy as Chief Strategy Officer of Strive. Mr. Roy's initial focus will be on Strive's intentions to monetize the operating business from the Semler Scientific subsidiary by expanding its mandate in early disease detection products.  Mr. Roy began his career in science at MIT and trained as a physician at Yale Medical School before joining Ba

    1/16/26 8:40:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Strive Appoints Ben Werkman as Chief Investment Officer to Advance Bitcoin Strategy

    DALLAS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. ("Strive" or the "Company") (NASDAQ:ASST) today announced the appointment of Ben Werkman as Chief Investment Officer ("CIO") reporting to Strive Chairman and Chief Executive Officer ("CEO") Matt Cole. A recognized Bitcoin advocate with a proven track record in corporate Bitcoin strategy and institutional finance, Mr. Werkman brings deep expertise in treasury strategy, implementation, capital allocation, equity and derivatives trading, and risk management.   Most recently, he served as CIO at Swan Bitcoin, where his focus has been on capital-raising initiatives and the implementation of the first treasury services partnership with a pu

    10/6/25 7:00:00 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction

    DALLAS, TX and CAMPBELL, CA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. ("Strive") entered into a definitive agreement to acquire Semler Scientific, Inc. ("Semler Scientific") in an all-stock transaction. In addition, Strive announced the purchase of 5,816 Bitcoin to its corporate treasury at an average price of $116,047 per Bitcoin, for a total purchase price of $675,000,000, inclusive of fees and expenses, bringing Strive's total Bitcoin holdings to 5,886. Transaction details: Deal represents an approximately 210% premium, equivalent to approximately $90.52 per share, based on the trading price of Semler Scientific common stock and Strive Class A common stock as of the market clos

    9/22/25 8:15:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ASST
    $KAVL
    $MVLA
    $TRML
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Tourmaline Bio Inc.

    SC 13G/A - Tourmaline Bio, Inc. (0001827506) (Subject)

    11/14/24 5:46:12 PM ET
    $TRML
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Tourmaline Bio Inc.

    SC 13G/A - Tourmaline Bio, Inc. (0001827506) (Subject)

    11/14/24 5:05:20 PM ET
    $TRML
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care